S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
2 Stocks to Benefit from the Aging Population
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Small Caps That Have Priced In A Hard Landing For Big Upside
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
2 Stocks to Benefit from the Aging Population
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Small Caps That Have Priced In A Hard Landing For Big Upside
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
2 Stocks to Benefit from the Aging Population
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Small Caps That Have Priced In A Hard Landing For Big Upside
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
Are Gene Therapy Stocks The Market's Next Big Winners?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
2 Stocks to Benefit from the Aging Population
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Small Caps That Have Priced In A Hard Landing For Big Upside
This May Have Ended Alibaba's Winter, But Is It Time To Buy?
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
AI Boosts Duolingo As Company Posts First Profit
Alcoa, Krispy Kreme fall; Williams-Sonoma, Ford rise, Monday, 9/25/2023
OTCMKTS:IOBCF

Ion Beam Applications (IOBCF) Stock Forecast, Price & News

$9.86
-0.14 (-1.40%)
(As of 09/25/2023 ET)
Compare
Today's Range
$9.86
$9.86
50-Day Range
$9.86
$16.30
52-Week Range
$9.86
$20.00
Volume
645 shs
Average Volume
507 shs
Market Capitalization
N/A
P/E Ratio
116.32
Dividend Yield
N/A
Price Target
N/A

IOBCF stock logo

About Ion Beam Applications (OTCMKTS:IOBCF) Stock

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

IOBCF Price History

IOBCF Stock News Headlines

IBA SA: IBA Reports Half Year 2023 Results
IBA Reports Half Year 2023 Results
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
IBA SA: IBA Business Update - First Quarter 2023
IBA Business Update – First Quarter 2023
See More Headlines
Receive IOBCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ion Beam Applications and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IOBCF
CIK
N/A
Fax
N/A
Employees
2,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Pierre Mottet (Age 61)
    Chairman of The Board
    Comp: $56.03k
  • Mr. Olivier Legrain (Age 55)
    CEO, Pres, MD & Exec. Director
    Comp: $939.14k
  • Mr. Yves Jongen (Age 76)
    Founder, Chief Research Officer, MD & Exec. Director
    Comp: $615.69k
  • Ms. Soumya Chandramouli (Age 44)
    Chief Financial Officer
  • Mr. Frederic Nolf (Age 50)
    Chief HR & Sustainability Officer
  • Marc Van der Burght
    Chief Operation Officer
  • Olivier Lechien
    Corp. Communication Director
  • Thomas Canon
    Sustainability Program Director
  • Bruno Scutnaire
    Pres of IBA RadioPharma Solutions













IOBCF Stock - Frequently Asked Questions

How have IOBCF shares performed in 2023?

Ion Beam Applications' stock was trading at $16.78 at the beginning of the year. Since then, IOBCF shares have decreased by 41.2% and is now trading at $9.86.
View the best growth stocks for 2023 here
.

Are investors shorting Ion Beam Applications?

Ion Beam Applications saw a drop in short interest in August. As of August 31st, there was short interest totaling 6,200 shares, a drop of 73.0% from the August 15th total of 23,000 shares. Based on an average trading volume of 700 shares, the days-to-cover ratio is currently 8.9 days.
View Ion Beam Applications' Short Interest
.

What is Ion Beam Applications' stock symbol?

Ion Beam Applications trades on the OTCMKTS under the ticker symbol "IOBCF."

How do I buy shares of Ion Beam Applications?

Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ion Beam Applications' stock price today?

One share of IOBCF stock can currently be purchased for approximately $9.86.

How many employees does Ion Beam Applications have?

The company employs 2,000 workers across the globe.

How can I contact Ion Beam Applications?

Ion Beam Applications' mailing address is 3, chemin du Cyclotron, Louvain-la-Neuve, Brussels Region. The official website for the company is www.iba-worldwide.com. The company can be reached via phone at (321) 047-5811.

This page (OTCMKTS:IOBCF) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -